174072-92-5

Basic information

• Product Name: Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 5-methyl-6-(4-nitrophenyl)-3-phenyl-
• CAS NO: 174072-92-5
• Molecular Formula: C19H13N3O4S
• Molecular Weight: 379.396
• Mol File: 174072-92-5.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 5-methyl-6-(4-nitrophenyl)-3-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 5-methyl-6-(4-nitrophenyl)-3-phenyl-(174072-92-5)
• EPA Substance Registry System: Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 5-methyl-6-(4-nitrophenyl)-3-phenyl-(174072-92-5)

Safety Data

• Hazardous Substances Data: 174072-92-5(Hazardous Substances Data)

Upstream product

• 103-71-9 phenyl isocyanate 
• 174072-89-0 2-Amino-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylic acid ethyl ester 
• 124-41-4 sodium methylate 

Downstream Products

• 174073-19-9 1-(2,6-difluorobenzyl)-5-methyl-6-(4-nitrophenyl)-3-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione 
• 174072-63-0 6-(4-aminophenyl)-5-(N-benzyl-N-methylaminomethyl)-1-(2,6-difluorobenzyl)-3-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione 
• 481049-95-0 N-(4-{5-{[benzyl(methyl)amino]methyl}-1-(2,6-difluorobenzyl)-3-phenyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl}phenyl)-N'-ethylurea 

Relevant articles and documents

PREMATURE OVULATION PREVENTIVE AGENT

The present invention provides a premature ovulation inhibitor for use in in vitro fertilization or embryo transfer process, which contains a nonpeptidic compound having a gonadotropin releasing hormone antagonistic action. The premature ovulation inhibitor for use in in vitro fertilization or embryo transfer process of the present invention is low toxic, permits oral administration, and has a superior inhibitory effect on premature ovulation in in vitro fertilization or embryo transfer process.

SUSTAINED RELEASE COMPOSITIONS

A composition prepared by containing or blending a physiologically active non-peptide substance and a biodegradable polymer having two or more carboxylic groups at its end or a salt thereof features: (1) larger content of the physiologically active non-peptide substance can be contained, as well as release of the same can be controlled or accelerated, whereby secure pharmaceutical effect is achieved; (2) when the physiologically active non-peptide substance causes subcutaneous stimulation, an activity of canceling the stimulation by strongly acidic group at its end is expected; and (3) high glass transition point and high stability.

Preventives/remedies for alzheimer's disease

The present invention provides an agent for the prophylaxis or treatment of Alzheimer's disease. The agent for the prophylaxis or treatment of Alzheimer's disease of the present invention containing a compound having a GnRH antagonistic action shows low toxicity and has a superior preventive and therapeutic effect on Alzheimer's disease.